Safety and tolerability profile of nefazodone

Journal of Psychopharmacology

Volumn 10, Issue SUPPL. 1, 1996, Pages 11-17

  Marcus, R N ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Depression; Interactions; Nefazodone; Side effects; Toxicity

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450; FLUOXETINE; IMIPRAMINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ASTHENIA; CONFUSION; CONSTIPATION; DEPRESSION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HEADACHE; HUMAN; KIDNEY FAILURE; LIVER DYSFUNCTION; MALE SEXUAL DYSFUNCTION; NAUSEA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SOMNOLENCE; TREMOR; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0029893511     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Armitage R, Yonkers K, Rush A J, Cole D, Novak K (1995) Nefazodone improves sleep efficiency and has little effect on REM sleep in depressed patients: I. Presented at 2nd International Congress of the World Federation of Sleep Research Societies
2. Balon R (1993) Sexual dysfunction during antidepressant treatment. J Clin Psychiatr 54: 209-212
3. Barr L C, Goodman W K, Price L H (1994) Physical symptoms associated with paroxetine discontinuation. Am J Psychiatr 151: 289
4. Breuel H-P, DeLeenheer I, Coninx L, Gammans R (1993) Comparisons of the cardiovascular effects of nefazodone, imipramine, and placebo in healthy elderly volunteers. Eur Neuropsychopharmacol Sept: 423
5. Caplik J, Talukder E, Roberts D, Kensler T, Schwiderski U (1994) Nefazodone and body weight change: a comparison of nefazodone and imipramine in placebo-controlled trials of treatment for major depression. Neuropsychopharmacology 10: abstract P-174-32:220S
6. Cohn C, Robinson D, Roberts D, O'Brien K, Ieni J R, Schwiderski U (1996) Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. J Clin Psychiatr (in press)
7. Erman M, Gillin C, Winokur A, Albala B (1995) Nefazodone improves sleep efficiency and has little effect on rem sleep in depressed patients: II. Presented at 2nd International Congress of the World Federation of Sleep Research Societies
8. Fava G A, Grandi S (1995) Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol 15: 374-375
9. Fawcett J, Marcus R N, Anton S F, O'Brien K, Schwiderski U (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatr 56 (suppl 6): 37-42
10. Feiger A, Kiev A, Shrivastava R, Wisselink P G, Wilcox C S (1996) Nefazodone versus sertaline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatr (in press)
11. Feighner J P, Pambakian R, Fowler R C, Boyer W F, D'Amico M F (1989) A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. Psychopharmacol Bull 25: 219-221
12. Fontaine R, Ontiveros A, Elie R, Kensler T T, Roberts D L, Kaplita S, Ecker J A, Faludi G (1994) A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatr 55: 234-241
13. Friedman L, Ecker J, Sullivan J, Kroft C, Cole J (1992) A comparative study of the abuse potential of nefazodone, amphetamine, diazepam and placebo in normal volunteers. Proc Eur Coll Neuropsychopharmacol Abstract, May
14. Frewer U, Lader M. (1993) The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects. Int Clin Psychopharmacol 8: 13-20
15. Frost L, Lal S (1995) Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. Am J Psychiatr 152: 810
16. Gold L H, Balster R L (1991) Evaluation of nefazodone self-administration in rhesus monkeys. Drug Alcohol Depend 28: 241-247
17. Hendrickse W A, Roffwarg H P, Grannemann B D, Oisulak P J, Armitage R, Cain J W, Battaglia J, Debus J R, Rush A J (1994) The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacology 10: 85-91
18. Kerkhofs M, Rielaert C, de Maertelaer V, Linkowski P, Czarka M, Mendlewicz J (1990) Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables. Int Clin Psychopharmacol 5: 253-260
19. Koopowitz L F, Berk M (1995) Paroxetine induced withdrawal effects. Hum Psychopharmacol 10: 147-148
20. Mendels J, Reimherr F, Marcus R N, Roberts D L, Francis R J, Anton S F (1995) A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatr 56 (suppl 6): 30-36
21. Mueller E A, Murphy D L, Sunderland T (1985) Neuroendocrine effects of m-chlorophenyl-piperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 61: 1179-1184
22. O'Hanlon J F, Freeman H L (1995) Categorising the behavioural toxicities of antidepressants: proposals and requirements. Br J Psychiatr 166: 421-423
23. Physicians Desk Reference (1995 and 1995 supplement S) Medical Economics Data, Montvale, NJ
24. Preskorn S H (1995) Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline and venlafaxone. J Clin Psychiatr 56 (suppl 6): 12-21
25. Rickels K, Schweizer E, Clary C, Fox I, Weise C (1994) Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatr 164: 802-805
26. Taylor D P, Carter R B, Eison A S, Mullins U L, Smith H L, Torrente J R, Wright R N, Yocca F D (1995) Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. J Clin Psychiatr 56 (suppl 6): 3-11
27. Van Laar M W, Arjes Willigenburg P P, Volkerts E R (1995) Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adults and elderly subjects. J Clin Psychopharmacol 15: 30-40
28. van Moffaert M, Pregaldien J L, Von Frenckell R, Gammans R (1994) A double-blind comparison of nefazodone and imipramine in the treatment of depressed patients. New Trends Exp Clin Psychiatr X: 85-87
29. Walsh A E S, Cowen P J (1994) Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment. J Clin Psychopharmacol 14: 268-273
30. Walsn AES, Hockney R A, Campling G, Cowen P J (1993) Neuroendocrine and temperature effects of nefazodone in healthy volunteers. Biol Psychiatr 33:115-119
31. Zajecka J, Fawcett J, Schaff M, Jeffries H, Guy C (1991) The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatr 52:66-68